◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksT › TEVA

Teva Pharmaceutical Industries Limited (TEVA) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-08-11

Teva Pharmaceutical Industries Limited (TEVA) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Tel Aviv-Yafo, Israel with about 31,173 employees. Its market capitalization is roughly $125 billion. In the fiscal year ended 2025-12-31, TEVA reported $17.3B in revenue and $1.4B in net income.

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

Interactive charts & full statements →

TEVA Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-31
Total Revenue$17.3B$16.5B$15.8B$14.9B
Gross Profit$8.9B$8.1B$7.6B$7.0B
Operating Income (EBIT)$4.0B$3.4B$3.2B$2.7B
Net Income$1.4B($1.6B)($559M)($2.4B)

ILS; ₪M / ₪B as marked. Newest period first. Source: company filings via the Israel Securities Authority’s Magna disclosure system.

TEVA Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Revenue$4.1B$4.0B$4.7B$4.5B$4.2B
Gross Profit$2.2B$2.0B$2.7B$2.3B$2.1B
Operating Income (EBIT)$149M$759M$1.3B$1.1B$899M
Net Income($576M)$369M$480M$433M$282M

ILS; ₪M / ₪B as marked. Newest period first. Source: company filings via the Israel Securities Authority’s Magna disclosure system.

TEVA Free Cash Flow History

TEVA Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$40.7B$39.3B$43.5B$44.0B
Total Liabilities$32.8B$33.6B$35.4B$35.4B

ILS; ₪M / ₪B as marked. Newest period first. Source: company filings via the Israel Securities Authority’s Magna disclosure system.

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive TEVA viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

This page in other languages: עברית

← TETAll “T” companiesTEX →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.